US OptionsDetailed Quotes
BMY250110P51000
- 0.01
- 0.000.00%
15min DelayClose Jan 8 16:00 ET
0.00High0.00Low
0.01Open0.01Pre Close0 Volume6 Open Interest51.00Strike Price0.00Turnover64.43%IV10.24%PremiumJan 10, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0107Delta0.0105Gamma5681.00Leverage Ratio-0.0097Theta0.0000Rho-60.76Eff Leverage0.0012Vega
Bristol-Myers Squibb Stock Discussion
Sign in to post a comment
The market decisively fell Friday, with the indexes pulling back. On Thursday, $Apple (AAPL.US)$ hit an all-time high of $260, just below the $4 T market cap. Friday, the market pulled back, with other big tech names joining Apple in pilling down indices. It is looking bleak for a "Santa Clause Rally" that sees the last seven sessions or so of the trading year end in an overall gain.
After the 4 pm close, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.77...
After the 4 pm close, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.77...
39
7
7
🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...
4
4
$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...
10
2
4
Buckle up! See FDA PDUFA update 👇
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont oral solution
$BeiGene (BGNE.US)$ ⇨ Tisleli...
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont oral solution
$BeiGene (BGNE.US)$ ⇨ Tisleli...
6
1
Buckle up! See FDA PDUFA update 👇🧵
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinece...
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinece...
4
Happy Monday, November 11th. The market climbed to a trifecta of closing highs for indices. The S&P 500 broke through 6k Friday and traded above the historic mark again Monday before the market pulled back in the afternoon.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +10 bps, the $Dow Jones Industrial Average (.DJI.US)$ climbed 69 bps, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.06%.
MACRO
In macroecon...
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +10 bps, the $Dow Jones Industrial Average (.DJI.US)$ climbed 69 bps, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.06%.
MACRO
In macroecon...
44
12
9
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Good morning, traders. Happy Monday, November 11th. The market is climbing, but some tech firms are pulling back after hitting post-election records. The S&P 500 broke through 6,000 Friday and traded above the historic mark again Monday.
My name is Kevin Travers; here is the news and animal spirits moving markets today.
$Monolithic Power Systems (MPWR.US)$ shares fell 22%, the lowest decliner on the S&P 500 and Nasdaq, after a report from analysts at Edgew...
My name is Kevin Travers; here is the news and animal spirits moving markets today.
$Monolithic Power Systems (MPWR.US)$ shares fell 22%, the lowest decliner on the S&P 500 and Nasdaq, after a report from analysts at Edgew...
44
5
6
Portfolio diversification is the strategy of spreading investments across different assets, sectors, industries, and geographical regions to reduce the overall risk of the portfolio. The idea is that by holding a variety of investments, the overall performance of the portfolio will be less dependent on the performance of any single investment, reducing the risk of large losses.
Why is Portfolio Diversification Important?
1. Risk Reduction:
Diversification...
Why is Portfolio Diversification Important?
1. Risk Reduction:
Diversification...
39
1
36
Stocks to Watch
Abbott Laboratories (ABT US) $Abbott Laboratories (ABT.US)$
Daily Chart -[BULLISH ↗ **]ABT US is currently holding above short term ascending trendline support. As long as price is holding above 117.30 support, a further push higher towards 1st resistance at 123.80 then next resistance at 131.20 is expected. Technical indicators are advocating for a bullish scenario as well.
Altern...
Abbott Laboratories (ABT US) $Abbott Laboratories (ABT.US)$
Daily Chart -[BULLISH ↗ **]ABT US is currently holding above short term ascending trendline support. As long as price is holding above 117.30 support, a further push higher towards 1st resistance at 123.80 then next resistance at 131.20 is expected. Technical indicators are advocating for a bullish scenario as well.
Altern...
+3
31
4
2
No comment yet
Sundar Subbarama : We still have a week to go for the Santa rally. Expecting a race to the top next Tuesday through Friday. Well Wednesday will be fireworks all around the World.
Stock_Drift : $Trump Media & Technology (DJT.US)$ $Microsoft (MSFT.US)$ $NVIDIA (NVDA.US)$ $Tesla (TSLA.US)$ $Nasdaq 100 (LIST91325.US)$ $S&P 500 Index (.SPX.US)$ $Dow Jones Industrial Average (.DJI.US)$ $Super Micro Computer (SMCI.US)$
Yeah, what a day Kevin!!! The market surprised me!! lol.
Have a good weekend.
103677010 : noted
104327919HO : noted
102710538 Sundar Subbarama : 为什么周5下跌呢？
View more comments...